ReviewBrain informatics2026
Multimodal fusion and explainability of artificial intelligence models in Alzheimer's Disease detection.
Review in Brain informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The integration of multimodal data has emerged as a powerful strategy for enhancing the accuracy and interpretability of artificial intelligence (AI) models in the diagnosis and prognosis of Alzheimer's Disease (AD). This systematic review presents a comprehensive synthesis of recent advances in AI-driven multimodal fusion approaches for AD prediction. A detailed examination of widely used datasets-including their modalities, preprocessing pipelines, and accessibility-is provided to aid reproducibility and methodological transparency. We analyze and categorize the various data harmonization and preprocessing techniques employed across neuroimaging (e.g., fMRI, sMRI, PET), electrophysiological (EEG), and genomic modalities, highlighting domain-specific practices and challenges. Furthermore, fusion strategies are classified into data-level, feature-level, decision-level, and temporal (early, intermediate, and late) paradigms, offering insights into their implementation and diagnostic impact. The review also investigates the adoption of explainable AI (XAI) techniques across studies and identifies a significant underrepresentation of works that simultaneously emphasize multimodality, explainability, and methodological rigor. By adhering to both PRISMA and Kitchenham's guidelines, this review ensures transparency and replicability in evidence synthesis. Compared to existing reviews, our work uniquely focuses on the intersection of multimodal integration and explainability within a systematically validated framework. The review concludes with recommendations for future research aimed at developing robust, interpretable, and clinically relevant AI models for AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.